Physician profile
Patrick Mixa
NPI 1033648647
$12,725.79
in general payments reported to CMS, 2019-2025
19 companies · $8,045 in 2025
The $8,045 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $841 · 2023: $1,248 · 2024: $2,591 · 2025: $8,045.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,440 · Food and Beverage: $5,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,440.49 |
| Food and Beverage | $5,443.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,896.25 | 2023-2025 | Real Intelligence, Ri Hip Navigation, Journey |
| Stryker Corporation | $3,765.78 | 2022-2025 | Mako, T2 Alpha, Variax |
| Arthrex, INC. | $1,627.38 | 2023-2025 | |
| Coastal Medical Technologies LLC | $808.99 | 2024-2025 | |
| Orthalign INC | $779.72 | 2025 | Orthalign Plus |
| Supreme Orthopedic Systems, LLC | $438.43 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $102.26 | 2022-2025 | |
| Integra Lifesciences Corporation | $50.77 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Globus Medical, INC. | $41.70 | 2022 | |
| Biocomposites INC | $36.00 | 2023 | Stimulan |
| Depuy Synthes Sales INC. | $26.18 | 2025 | Va-Lcp |
| Ucb, INC. | $25.50 | 2023 | Briviact |
| Banner Life Sciences, LLC | $21.85 | 2023 | |
| Amgen INC. | $20.97 | 2023 | Evenity, Prolia |
| Pfizer INC. | $20.44 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $20.19 | 2025 | Exparel |
| Heron Therapeutics, INC. | $16.70 | 2025 | Zynrelef |
| Sanara Medtech INC. | $14.30 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mixa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.